Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Dr. Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Medical University of South Carolina | United States

Author Profile

Orcid ID

🌟 SAMI I. NASSAR: A DEDICATED JOURNEY IN MEDICINE AND RESEARCH

EARLY ACADEMIC PURSUITS 🎓

Sami I. Nassar began his academic journey at Columbia University, where he majored in Neuroscience and Behavior, graduating Cum Laude in 2019 with an impressive GPA of 3.94/4.00. His academic excellence earned him a place in the Psi Chi International Honor Society in Psychology for his outstanding achievements. This strong foundation in neuroscience laid the groundwork for his future medical career. He is currently pursuing his MD at Wayne State University, School of Medicine, where he is on track to graduate in June 2024, having achieved a Step 2 Score of 258—a testament to his dedication to medical excellence.

PROFESSIONAL ENDEAVORS 👨‍⚕️

Throughout his career, Nassar has actively engaged in clinical and research positions across prestigious institutions. His experience as a Research Fellow at the Medical University of South Carolina since 2024 has enabled him to delve into otolaryngological topics, including vertiginous disorders and suicide risk in head and neck cancer patients. At the Henry Ford Health System and Karmanos Cancer Institute, he contributed to significant research on molecular biomarkers and substance use among cancer patients, helping to push the boundaries of cancer research and patient care. His earlier roles, including work at Generation Next Fertility and Columbia University, demonstrate his practical skills in clinical and laboratory settings, offering a holistic approach to patient care and research. These roles also gave him experience in collaborating with medical professionals and managing clinical trials, which have been integral to his development as a medical researcher.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS AND GENOMICS 🔬

Nassar’s research has focused heavily on otolaryngology, head and neck cancer, and HPV-related carcinomas. His work on identifying molecular biomarkers and risk factors in cancer patients, such as those for suicide and substance use, has been groundbreaking. His research not only seeks to understand the molecular foundations of cancer but also aims to improve the quality of life for cancer patients. His investigations into tinnitus and vertiginous disorders add further depth to his research portfolio, contributing to patient outcomes in the field of ear, nose, and throat (ENT) medicine.

IMPACT AND INFLUENCE 🏆

Nassar's research has been widely recognized within the medical community, as seen through numerous awards. His work has been presented at leading conferences, such as the American Head and Neck Society's 11th International Conference, where he won the 3rd place poster award in the Education/Care Delivery category. His earlier recognition by the American Journal of Gastroenterology in 2021 further highlights his ability to contribute to diverse fields of medicine. His influence extends to peer-reviewed academic journals, where his manuscripts and abstracts have garnered attention, solidifying his reputation as a promising researcher.

ACADEMIC CITES 📚

Nassar’s work has been cited in reputable journals, including Cancer Epidemiology, Biomarkers & Prevention, and the American Journal of Gastroenterology. His published work on topics like teduglutide therapy for Short Bowel Syndrome and cancer epidemiology reflects his ability to contribute to high-impact scientific literature. These citations, alongside his ongoing manuscripts on suicide and substance use in cancer patients, illustrate his influence on ongoing medical research.

LEGACY AND FUTURE CONTRIBUTIONS 🌍

As a young and promising researcher, Nassar is poised to make even more significant contributions to the field of medicine. His research on biomarkers and immunochemotherapy for cancer treatment, as well as his ongoing investigation into the psychological aspects of cancer care, will likely have a lasting impact on both academic research and clinical practice. His focus on improving patient quality of life through research on mental health and substance use demonstrates his commitment to a holistic approach to medicine, one that integrates both physical and mental health outcomes. His legacy will undoubtedly include shaping future practices in otolaryngology, head and neck oncology, and biomolecular cancer therapy. With his continued drive and dedication, Nassar’s future contributions to medical science promise to push boundaries and pave the way for innovative treatments and care models.

NOTABLE PUBLICATIONS 📑

"S3030 Safety and Efficacy of Teduglutide Therapy for Management of Short Bowel Syndrome After Intestinal Transplantation" 

  • Authors: Sami I. Nassar; Syed-Mohammed Jafri
  • Journal: American Journal of Gastroenterology
  • Year: 2021

"Abstract C067: Disparities in health literacy in patients with head and neck cancer: Considerations for understanding" 

  • Authors: Aleksandra Vidovich; Amy Williams; Samantha H. Tam; Mary K. Miller; Maria Olex; Sami Nassar; Alex Rodriguez; Eric Adjei Boakye
  • Journal: Cancer Epidemiology, Biomarkers & Prevention
  • Year: 2023

"The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine"

  • Authors: Sami I. Nassar; Amber Suk; Shaun A. Nguyen, MD; Dauren Adilbay; John Pang; Cherie-Ann Nathan
  • Journal: Cancer
  • Year: 2024

Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

Dr. Flavio Faletra | Cardiovascular Genetics and Genomics | Best Researcher Award 

University Health Authority of Central Friuli | Italy

Author Profile

Scopus
Orcid ID

Biography of Flavio Faletra: A Leader in Medical Genetics 🧬

EARLY ACADEMIC PURSUITS 🎓

Flavio Faletra began his distinguished academic journey at the University of Trieste, where he earned a Degree in Medicine and Surgery in 2005. He further specialized in Medical Genetics at the same institution, completing his specialization in 2009. Demonstrating a strong commitment to his field, Faletra pursued advanced education with a Second-level Master’s degree in Clinical Genetics from the University of Siena in 2011. His foundational academic achievements laid the groundwork for a career focused on the intersection of genetics and clinical medicine.

PROFESSIONAL ENDEAVORS 🏥

Flavio Faletra has held multiple pivotal roles in medical genetics. Since August 2023, he has been an Expert in Genetics at the Regional Health Coordination Agency (ARCS) in Friuli Venezia Giulia, Italy. Alongside his expert role, he has been a University Lecturer on contract at the University of Trieste from 2018 to 2023, contributing to the academic growth of students in the field of genetics. His professional journey includes numerous positions as a Medical Director I Level in Medical Genetics, starting with the IRCCS Burlo Garofolo (2013–2017) and progressing through roles in University Health Authority Friuli Centrale and IRCCS Burlo Garofolo until his current position, reflecting his leadership in the medical genetics field.

CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR GENETICS AND GENOMICS  🔬

Faletra’s research focus spans various critical areas of medical genetics, from pediatric endocrinology to rare genetic diseases. He has contributed extensively to genetic counseling and clinical genetics, with a strong emphasis on pediatric genetic disorders. His work as a Thesis Co-Surveyor and PhD Supervisor at the University of Trieste demonstrates his dedication to nurturing the next generation of geneticists. Through courses such as the Genetic Consulting in Medical Genetics Specialization School, he has shaped the landscape of medical genetics education. His involvement in pediatric endocrinology through ADE courses has brought syndromic genetic disorders to the forefront, significantly impacting the medical community’s approach to these conditions.

IMPACT AND INFLUENCE 🌍

Faletra’s influence extends beyond academia into clinical practice, where his expertise has helped shape genetic diagnostic strategies across Italy. His participation in national conferences, such as the National Congress of Human Genetics and seminars on genetic syndromes and diagnostics, marks him as a key figure in Italian medical genetics. Faletra's teaching and research efforts have particularly impacted the areas of growth retardation, fetal malformations, and syndromic genetic disorders, positioning him as a central figure in advancing genetic medicine in pediatrics.

ACADEMIC CITES 📚

Flavio Faletra's work has been cited in numerous academic publications, with topics ranging from genetic diagnostic methods to therapeutic approaches for rare genetic disorders. His research in exome sequencing and next-generation sequencing techniques has had a broad impact, being referenced widely in the fields of human genetics and pediatric medicine.

LEGACY AND FUTURE CONTRIBUTIONS 🏅

Faletra’s legacy lies in his dedication to medical genetics, particularly in the areas of pediatric syndromic diseases and clinical genetics. His contribution to education, research, and clinical practice has left an indelible mark on the field. Looking ahead, his ongoing role as an expert and lecturer promises continued contributions to genomic medicine and the advancement of personalized treatment for genetic disorders. Through his continuous involvement in research, teaching, and clinical practice, Faletra remains at the forefront of innovation in medical genetics, with the potential to further revolutionize the diagnosis and treatment of complex genetic diseases.

NOTABLE PUBLICATIONS 📑

"SRSF1 haploinsufficiency is responsible for a syndromic developmental disorder associated with intellectual disability" 

  • Authors: Bogaert, E., Garde, A., Gautier, T., Dermaut, B., Vitobello, A.
  • Journal: American Journal of Human Genetics
  • Year: 2023

"Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of CSNK2B-Associated Disorders" 

  • Authors:Di Stazio, M., Zanus, C., Faletra, F., d’Adamo, A.P., Musante, L.
  • Journal: Genes
  • Year: 2023

"A new neurodevelopmental disorder linked to heterozygous variants in UNC79"

  • Authors: A., Liu, Z., Luo, S., Liao, W., & Ren, D.
  • Journal: Genetics in Medicine
  • Year: 2023

"The clinical impact of the first-trimester nuchal translucency between the 95th–99th percentiles"

  • Authors: Fantasia, I., Catagini, S., Zamagni, G., Feresin, A., & Stampalija, T.
  • Journal: Prenatal Diagnosis
  • Year: 2023

"A bird’s eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases"

  • Authors: Zucco, J., Baldan, F., Allegri, L., Damante, G., Mio, C.
  • Journal: Journal of Human Genetics
  • Year: 2024

Jinghan Song | Bioactive Materials and Genomic Research | Best Scholar Award

Ms. Jinghan Song | Bioactive Materials and Genomic Research | Best Scholar Award

The Fourth Military University  | China

Author Profile 

Scopus

EARLY ACADEMIC PURSUITS

Jinghan Song demonstrated exceptional academic prowess early on, laying a solid foundation during their undergraduate studies at Xi’an Jiaotong University. With a Bachelor of Science in Medicine, Jinghan excelled in major courses such as Bioinformatics, Physiology, Immunology, and Pathology, achieving an impressive average score of 90.1/100.

PROFESSIONAL ENDEAVORS

Building upon their undergraduate success, Jinghan pursued a Master of Science in Medicine at The Fourth Military Medical University. Throughout their academic journey, they delved into advanced topics including Advances in Cell Biology, Electron Microscopy, and Tissue Engineering and Regenerative Medicine. Their commitment to excellence is evident in their remarkable average score of 85.47/100.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOACTIVE MATERIALS AND GENOMIC RESEARCH

Jinghan has contributed significantly to the field of biomedical research, notably as a member of projects focusing on innovative materials and their applications. Noteworthy projects include the development of collagen materials cross-linked with DNA and the preparation method and application of polyphosphate modified collagen material. These endeavors underscore Jinghan's dedication to advancing biomedical science through innovative research.

IMPACT AND INFLUENCE

Jinghan's research has garnered attention within the academic community, as evidenced by their participation in prestigious academic conferences such as the 25th Academic Conference of Chinese Stomatological Association, where they presented posters and gave oral presentations. Their contributions have earned them recognition, including the First Prize for Poster at the aforementioned conference.

ACADEMIC CITATIONS

Jinghan's work has the potential for significant academic impact, as indicated by their involvement in patent projects and participation in academic conferences. Their research outputs may serve as valuable references for future studies in the fields of biomaterials and regenerative medicine.

LEGACY AND FUTURE CONTRIBUTIONS

As an outstanding graduate of Xi’an Jiaotong University and a recipient of multiple scholarships and awards, Jinghan is poised to make enduring contributions to the field of medicine and biomedical research. Their dedication to academic excellence and innovative research methodologies positions them as a promising scholar with the potential to shape the future of healthcare and biotechnology.

Notable Publications

Advances in materials-based therapeutic strategies against osteoporosis 2023(20)

Engineered extracellular vesicles: Regulating the crosstalk between the skeleton and immune system 2022(7)

Inflammation-associated ectopic mineralization 2023(1)